¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Cell, alpha"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
adult T-cell leukemia/lymphoma
¼ºÀÎT¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
anaplastic large cell lymphoma
¿ªÇü¼ºÅ«¼¼Æ÷¸²ÇÁÁ¾
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell adenoma
¹Ù´Ú¼¼Æ÷»ùÁ¾, ±âÀú¼¼Æ÷¼±Á¾
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
basal cell epithelioma
¹Ù´Ú¼¼Æ÷»óÇÇÁ¾, ±âÀú¼¼Æ÷»óÇÇÁ¾
basal cell nevus
¹Ù´Ú¼¼Æ÷¸ð¹Ý, ±âÀú¼¼Æ÷¸ð¹Ý
basal cell nevus syndrome
¹Ù´Ú¼¼Æ÷¸ð¹ÝÁõÈıº, ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº
basket cell
¹Ù±¸´Ï¼¼Æ÷
basophilic cell
È£¿°±â¼¼Æ÷
basosquamous cell acanthoma
¹Ù´ÚÆíÆò¼¼Æ÷°¡½Ã¼¼Æ÷Á¾, ±âÀúÆíÆò±Ø¼¼Æ÷Á¾
basosquamous cell carcinoma
¹Ù´ÚÆíÆò¼¼Æ÷¾ÏÁ¾, ±âÀúÆíÆò¼¼Æ÷¾ÏÁ¾
beta cell
º£Å¸¼¼Æ÷
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
perivascular cell
Ç÷°üÁÖÀ§¼¼Æ÷
plasma cell
ÇüÁú¼¼Æ÷
polynucleated cell
¹µÇÙ¼¼Æ÷
prickle cell
°¡½Ã¼¼Æ÷
principal cell
ÁÖ¼¼Æ÷, À¸¶ä¼¼Æ÷
Purkinje cell
1. ½ÉÀåÀüµµ±ÙÀ°¼¼Æ÷, 2. Á¶·Õ¹Ú¼¼Æ÷
pyramidal cell
ÇǶó¹Ìµå¼¼Æ÷
red blood cell
ÀûÇ÷±¸
reserve cell
¿¹ºñ¼¼Æ÷
resting cell
ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
reticuloendothelial cell
±×¹°³»ÇǼ¼Æ÷, ¼¼¸Á³»ÇǼ¼Æ÷
rod cell
¸·´ë¼¼Æ÷
round cell
¿øÇü¼¼Æ÷
satellite cell
À§¼º¼¼Æ÷
scavenger cell
û¼Ò¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
cell-bound antibody
(¢¡cell-fixed antibody) ¼¼Æ÷°áÇÕÇ×ü
cell-fixed antibody
¼¼Æ÷°áÇÕÇ×ü
clear cell acanthoma
Åõ¸í¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
clear cell adenocarcinoma
Åõ¸í¼¼Æ÷»ù¾ÏÁ¾
crescent cell anemia
Ãʽ´ÞÀûÇ÷±¸ºóÇ÷
helper cell activity
µµ¿ò¼¼Æ÷´É, Á¶·Â¼¼Æ÷´É
islet cell adenoma
¼¶¼¼Æ÷»ùÁ¾
large cell acanthoma
Å«¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
red cell aplasia
ÀûÇ÷±¸¹«Çü¼º
sickle cell anemia
³´ÀûÇ÷±¸ºóÇ÷
subependymal giant cell astrocytoma
³ú½Ç¸·¹Ø°Å´ë¼¼Æ÷º°¼¼Æ÷Á¾, »óÀÇÇϰŴ뼼Æ÷º°¼¼Æ÷Á¾
target cell anemia
Ç¥ÀûÀûÇ÷±¸ºóÇ÷
balloon cell
dz¼±¼¼Æ÷
balloon cell melanoma
dz¼±¼¼Æ÷Èæ»öÁ¾
balloon cell nevus
dz¼±¼¼Æ÷¸ð¹Ý
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
alpha-adrenal receptor antagonist
¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
alpha-adrenergic agonist
¾ËÆÄ¾Æµå·¹³¯¸°ÃËÁøÁ¦
alpha-adrenergic antagonist
¾ËÆÄ¾Æµå·¹³¯¸°±æÇ×Á¦
alpha-adrenergic receptor
¾ËÆÄ-¾Æµå·¹³¯¸°¼ö¿ëü.
alpha-adrenergic receptor
¾ËÆÄ¾Æµå·¹³¯¸°¼ö¿ëü
alpha-amino acid nitrogen
¾ËÆÄ-¾Æ¹Ì³ë»êÁú¼Ò
alpha-chain disease
¾ËÆÄ¼â Áúȯ(¡áð òðü´)
alpha-chymotrypsin
¾ËÆÄÄ«ÀÌ¸ðÆ®¸³½Å
alpha-fetoprotein
¾ËÆÄžƴܹé
alpha-fetoprotein
¾ËÆÄ-žƴܹé(¡÷Ãä®Ó±ÛÜ)
alpha-fucosidase
¾ËÆÄ-ǪÄڽôÙÁ¦(¡ð¥)
alpha-ketoglutarate
¾ËÆÄ-ÄÉÅä±Û·çŸ·¹ÀÌÆ®
alpha-l-iduronidase
a-L-Iduronidase
alpha-lipoproteinemia
¾ËÆÄ-Áö¹æ´Ü¹éÇ÷Áõ
alpha-naphthyl acetate esterase
¾ËÆÄ-³ªÇÁÆ¿¾Æ¼¼Å×ÀÌÆ®¿¡½ºÅ×¶óÁ¦
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
alpha thalassemia
¾ËÆÄÅ»¶ó¼¼¹Ì¾Æ.
alpha toxin
¾ËÆÄ µ¶¼Ò (¡Ô¸áÈ)
alpha wave
¾ËÆÄÆÄ ³úÆÄ(Òà÷î)ÀÇ .
alpha-1-antittrypsin deficiensy
¾ËÆÄ-1-¾ÈƼƮ¸³½Å °áÇÌÁõ(¡ÌÀù¹ñø)
alpha-2-macroglobulin
¾ËÆÄ-2-¸¶Å©·Î±Û·ÎºÒ¸°
alpha-adrenal receptor antagonist
¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
alpha-adrenergic agonist
¾ËÆÄ¾Æµå·¹³¯¸°ÃËÁøÁ¦
alpha-adrenergic antagonist
¾ËÆÄ¾Æµå·¹³¯¸°±æÇ×Á¦
alpha-adrenergic receptor
¾ËÆÄ-¾Æµå·¹³¯¸°¼ö¿ëü.
alpha-adrenergic receptor
¾ËÆÄ¾Æµå·¹³¯¸°¼ö¿ëü
alpha-amino acid nitrogen
¾ËÆÄ-¾Æ¹Ì³ë»êÁú¼Ò
alpha-chain disease
¾ËÆÄ¼â Áúȯ(¡áð òðü´)
alpha-chymotrypsin
¾ËÆÄÄ«ÀÌ¸ðÆ®¸³½Å
alpha-fetoprotein
¾ËÆÄžƴܹé
alpha-fetoprotein
¾ËÆÄ-žƴܹé(¡÷Ãä®Ó±ÛÜ)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½